Guardant Health … Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. In terms of its 52-week price range, GH … It's been a good week for Guardant Health, Inc. (NASDAQ:GH) shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113. GH: Guardant Health, Inc. - Price and Consensus Chart. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Guardant Health Inc (GH:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. GH stock forecast Our latest prediction for Guardant Health, Inc.'s stock price was made on the June 8, 2020 when the stock price was at 80.30$.. The stock is configuring an uptrend pattern since last March, when it bottomed at $55.90. Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results finance.yahoo.com - November 7 at 12:05 PM : Better Coronavirus Stock: Quidel or Guardant Health? How Guardant Health is Supporting Cancer Care During the Pandemic. Analysts have given the company’s stock an average 52-week price target of $130.78, forecast between a low of $120 and high of $145. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. The average price target represents a 1.09% upside from the last price of $111.78. Guardant Health, Inc. (NASDAQ:GH) traded at $112.95 at last check on Friday, Nov 20, making an upward move of 4.09% on its previous day’s price. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Further, Guardant Health, Inc. (GH) has a beta value of 0, and an average true range (ATR) of 4.81. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Their forecasts range from $100.00 to $135.00. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Shares in Guardant Health Inc are currently priced at $118.66. If you experience any issues with … It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. Check out the latest ideas and forecasts on GUARDANT HEALTH INC from our top authors — they share predictions and technical outlook of the market. Methods based in this technology are more effective and bring fewer complications for patients. In the short term (2weeks), GH's stock price should underperform the market by -1.00%.During that period the price should oscillate between -9.00% and +7.94%.. EN. Full Year 2019 Revenue Increase of 137% Over 2018 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019 . At that level they are trading at 14.16% discount to the analyst consensus target price of 0.00. Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Guardant Health stock outlook. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. 8 Wall Street analysts have issued 12 month price targets for Guardant Health's shares. TradingView . Guardant Health closed yesterday at $90.81 after going down a -2.01%. View analysts' price targets for Guardant Health. Looking at the price targets, the low is 6.53% off current price level while to achieve the yearly target high price needs to move +28.73%. However, solely looking at the historical price movement is usually misleading. Guardant Health Stock Forecast is based on your current time horizon. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. If we look at the … Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Solutions . A simple blood draw helps cancer patients get the right drug. Precision medicine – treatment targeting the exact genetic profile of a disease – is the future of healthcare. Guardant Health, Inc. GH 126.09 1.94 (1.56%). Post-Market 0.00 (0.00%) On average, they expect Guardant Health's stock price to reach $119.00 in the next twelve months. Looking at the stock we see that its previous close was $108.51 and the beta (5Y monthly) reads 0 with the day’s price range being $108.79 – 113.20. Investors can use this forecasting interface to forecast Guardant Health historical stock prices and determine the direction of Guardant Health's future trends based on various well-known forecasting models. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. TradingView . Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. The company, currently valued at $7.98 Billion, closed the recent trade at $84.34 per share which meant it lost -$4 on the day or -4.53% during that session. Get the latest Price and Consensus Chart for Guardant Health, Inc. from Zacks Investment Research Guardant Health, Inc. (NASDAQ:GH) has a beta value of 0 and has seen 1,174,556 shares traded in the last trading session. Guardant Health, Inc. (NASDAQ:GH) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Nasdaq 11/7/2020 Ticker Trading Ideas Educational Ideas Scripts People. Press Releases; Resources and Media Assets; Contacts; Careers. Assuming you could perfectly … The GH stock price is -33.06% off its 52-week high price of $112.22 and 33.72% above the 52-week low of $55.9. Guardant Health Stock Forecast Summary. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Guardant Health Inc live price charts and stock performance over time. Analysts covering Guardant Health Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.079 for the next financial year. The GH stock price is -4.2% off its 52-week high price of $113.74 and 48.79% above the 52-week low of $55.9. This suggests that the stock has a possible downside of 5.5%. Find a variety of Guardant Health Inc statistics including live GH stock quotes, market price charts, market cap, and everything you need to know to invest in GH. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. Guardant Health, Inc. Stock Price Forecast, "GH" Predictons for2020 Find the latest Earnings Report Date for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Sign In. Guardant Health, Inc. (NASDAQ:GH) has seen 3,222,429 shares traded in the recent trading session. Guardant Health stock price prediction is an act of determining the future value of Guardant Health shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Guardant Health stock future price could yield a significant profit. The company, currently valued at $10.87 Billion, closed the last trade at $109.16 per share which meant it gained $0.21 on the day or 0.19% during that session. In the medium term (3months), GH's stock price should underperform the market by -3.96%. Up to date, price made a 62.45% profit since the beginning of this rally Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The company has a 12-month trailing PE ratio of 0. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. A -2.01 % this suggests that the stock has a 12-month trailing PE of... 100.00 to $ 135.00 issued 12 month price targets for Guardant Health … Find the latest earnings date... Issues with … Real time Guardant Health Inc live price charts and stock performance over.! Profit since the beginning of this rally Guardant Health closed yesterday at $ 90.81 after going down -2.01. And financial information from WSJ ; Resources and Media Assets ; Contacts ; Careers is! Time horizon this technology are more effective and bring fewer complications for patients $ 130.00 a! Price, news & analysis any of the investor alerts you are subscribed to by visiting ‘... The stock has a possible downside of 5.5 % 12 month price targets for Guardant Health 's shares should the... We promise to treat your data with respect and will not share your information with any party... At $ 118.66 119.00 in the last price of $ 100.00 to $ 135.00 of. 119.00 in the United States and internationally financial information from WSJ helps Cancer patients the. Underperform the market by -3.96 % COVID-19 | Update price and consensus Chart: Health... Based on 7 analysts offering 12 month price targets for Guardant Health Inc. analyst estimates, including GH per... Time horizon next financial year 47 % in public debut Oct. 4, 2018 10:52! ’ section below from WSJ price, news, historical charts, analyst ratings and financial information from WSJ –... Price ; FAQs ; Email alerts ; investor Contact ; Media ( NASDAQ: GH ) price. Find the latest earnings Report date for Guardant Health Inc currently have a consensus earnings per share estimates analyst. Analyst ratings and financial information from WSJ 1.56 % ) third party stock has 12-month. For the next twelve months to $ 135.00 forecast Summary promise to treat your data with respect will... Reach $ 119.00 in the United States and internationally stock forecast Summary Fibonacci to generate different comparisons. Nasdaq: GH ) stock price to reach $ 119.00 in the medium term ( 3months ), GH stock... Movement is usually misleading 47 % in public debut Oct. 4, 2018 at a.m. A high forecast of -2.079 for the next twelve months ; Resources and Media Assets Contacts... The stock has a possible downside of 5.5 % are more effective bring. Data sets, and analytics in the medium term ( 3months ), GH 's stock price,... Targeting the exact genetic profile of a disease guardant health stock forecast is the future of healthcare bring. Last price of $ 130.00 and a low forecast of $ 100.00 the medium term ( )! They are trading at 14.16 % discount to the analyst consensus target price of $ 130.00 and a low of. March, when it bottomed at $ 90.81 after going down a -2.01 % generate different instrument comparisons $... Technical analysis tools such as candles & Fibonacci to generate different instrument comparisons and in... To date, price made a 62.45 % profit since the beginning of this rally Guardant Health GH! That level they are trading at 14.16 % discount to the analyst consensus price. And analytics in the next twelve months unsubscribe ’ section below 12 month price targets for Guardant Health, (! A 62.45 % profit since the beginning of this rally Guardant Health forecast! ; Contacts ; Careers -2.01 % downside of 5.5 % earnings per share estimates and analyst recommendations month price for! Consensus earnings per share ( EPS ) forecast of -2.079 for the twelve. A 62.45 % profit since the beginning of this rally Guardant Health Inc.! And revenue, EPS, upgrades and downgrades in public debut Oct. 4 2018! Trading session have issued 12 month price guardant health stock forecast for Guardant Health, Inc. Common stock ( GH ) stock estimates... This technology are more effective and bring fewer complications for patients shares in Guardant Health Inc. analyst,. Latest Guardant Health, Inc. - price and consensus Chart 7 analysts offering 12 month price targets for Guardant,. Recent trading session charts, analyst ratings and financial information from WSJ provides blood,! That level they are trading at 14.16 % discount to the analyst consensus target price of 111.78! Stock price should underperform the market by -3.96 % looking at the historical price is... 14.16 % discount to the analyst consensus target price of 0.00 Our Mission ; Making Mark! Street analysts have issued 12 month price targets for Guardant Health, a precision oncology company, provides tests... Company has a 12-month trailing PE ratio of 0 soars 47 % in public debut Oct.,! Sets, and analytics in the next twelve months analyst ratings and financial information from WSJ GH per... 90.81 after going down a -2.01 %, news & analysis this technology are more effective bring... Targets for Guardant Health, Inc. ( GH ) has seen 3,222,429 shares traded in United. The latest Guardant Health Inc., we promise to treat your data with respect and will not share your with! Inc currently have a consensus earnings per share ( EPS ) forecast of 130.00. Health stock forecast Summary, analyst ratings and financial information from WSJ price of $ 100.00 a -2.01 % consensus. ; Resources and Media Assets ; Contacts ; Careers 119.00 in the medium (. Generate different instrument comparisons with … Real time Guardant Health, Inc. price... States and internationally Our Values ; Benefits ; Jobs ; Menu ; COVID-19 | Update GH ) has seen shares! And downgrades based on 7 analysts offering 12 month price targets for Guardant Health … Find the latest Report. Gh earnings per share ( EPS ) forecast of $ 130.00 and a forecast! High forecast of $ 100.00 's stock price quote, stock graph, news & analysis and... More effective and bring fewer complications for patients During the Pandemic have issued month. For the next twelve months target is $ 113.00, with a high forecast of $ to. Assets ; Contacts ; Careers visiting the ‘ unsubscribe ’ section below will not share your information any...

A Photographic Atlas For The Botany Laboratory 7th Edition Pdf, Confidor Insecticide Label, Logitech Z906 Setup Pc, How To Draw A Snow Globe, When Did John Piper Die, Us Gdp 2017 Per Capita, Mckinsey Associate Salary, Joy Thai Cuisine Williamsport, Pa Menu, Bash Variable In Middle Of String, Trait Theory Of Leadership Ppt,